Human Molecular Genetics Advance Access published online on February 23, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl032
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Colleen Giblin Laboratories for Pediatric Neurology Research, Department of Neurology, Columbia University, New York, NY, USA
* To whom correspondence should be addressed. Glut-1 deficiency syndrome (Glut-1 DS (OMIM #606777) is characterized by infantile seizures, developmental delay, acquired microcephaly, and hypoglycorrhachia. It is caused by haploinsufficiency of the blood-brain barrier hexose carrier. Heterozygous mutations or hemizygosity of the GLUT-1 gene cause Glut-1 DS. We generated a heterozygous haploinsufficient mouse model by targeted disruption of the promoter and exon 1 regions of the mouse GLUT-1 gene. GLUT-1+/- mice have epileptiform discharges on EEG, impaired motor activity, incoordination, hypoglycorrhachia, micrencephaly, decreased brain glucose uptake as measured by PET scan, and decreased brain Glut-1 expression by western blot (66%). The GLUT-1+/- murine phenotype mimics the classical human presentation of Glut-1 DS. This GLUT-1+/- mouse model creates an opportunity to investigate Glut-1 function, to examine the pathophysiology of Glut-1 DS in vivo, and to evaluate new treatment strategies.
Received December 12, 2005
Revised February 8, 2006
Accepted February 15, 2006
Article
A mouse model for glut-1 haploinsufficiency
Dong Wang 1,
Juan M. Pascual 1,
Hong Yang 1,
Kristin Engelstad 1,
Xia Mao 1,
Jianfeng Cheng 2,
Jong Yoo 3,
Jeffrey L. Noebels 3,
and
Darryl C. De Vivo 4 *
2 Department of Psychiatry, Columbia University, Division of Biostatistics, New York State Psychiatric Institute, New York, NY, USA
3 Developmental Neurogenetics Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX, USA
4 Sidney Carter Professor of Neurology, Professor of Pediatrics, Colleen Giblin Laboratories for Pediatric Neurology Research, Department of Neurology, Columbia University, Neurological Institute, 710 West 168th Street, New York, NY, USA
Darryl C. De Vivo, E-mail: dcd1{at}columbia.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Perez-Duenas, C. Prior, Q. Ma, E. Fernandez-Alvarez, X. Setoain, R. Artuch, and J. M. Pascual Childhood Chorea With Cerebral Hypotrophy: A Treatable GLUT1 Energy Failure Syndrome Arch Neurol, November 1, 2009; 66(11): 1410 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vijayaraj, C. Kroger, U. Reuter, R. Windoffer, R. E. Leube, and T. M. Magin Keratins regulate protein biosynthesis through localization of GLUT1 and -3 upstream of AMP kinase and Raptor J. Cell Biol., October 19, 2009; 187(2): 175 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carruthers, J. DeZutter, A. Ganguly, and S. U. Devaskar Will the original glucose transporter isoform please stand up! Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E836 - E848. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Magistretti Role of glutamate in neuron-glia metabolic coupling Am. J. Clinical Nutrition, September 1, 2009; 90(3): 875S - 880S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Schmidt, A Hommel, V Gawlik, R Augustin, N Junicke, S Florian, M Richter, D J Walther, D Montag, H-G Joost, et al. Essential role of glucose transporter GLUT3 for post-implantation embryonic development J. Endocrinol., January 1, 2009; 200(1): 23 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schmidt, M. Richter, D. Montag, T. Sartorius, V. Gawlik, A. M. Hennige, S. Scherneck, H. Himmelbauer, S. Z. Lutz, R. Augustin, et al. Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1084 - E1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Coan, E. Angiolini, I. Sandovici, G. J. Burton, M. Constancia, and A. L. Fowden Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice J. Physiol., September 15, 2008; 586(18): 4567 - 4576. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Simpson, D. Dwyer, D. Malide, K. H. Moley, A. Travis, and S. J. Vannucci The facilitative glucose transporter GLUT3: 20 years of distinction Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E242 - E253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pascual, D. Wang, R. Yang, L. Shi, H. Yang, and D. C. De Vivo Structural Signatures and Membrane Helix 4 in GLUT1: INFERENCES FROM HUMAN BLOOD-BRAIN GLUCOSE TRANSPORT MUTANTS J. Biol. Chem., June 13, 2008; 283(24): 16732 - 16742. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Khan, T. Hanada, M. Mohseni, J.-J. Jeong, L. Zeng, M. Gaetani, D. Li, B. C. Reed, D. W. Speicher, and A. H. Chishti Dematin and Adducin Provide a Novel Link between the Spectrin Cytoskeleton and Human Erythrocyte Membrane by Directly Interacting with Glucose Transporter-1 J. Biol. Chem., May 23, 2008; 283(21): 14600 - 14609. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ganguly, R. A. McKnight, S. Raychaudhuri, B.-C. Shin, Z. Ma, K. Moley, and S. U. Devaskar Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1241 - E1255. [Abstract] [Full Text] [PDF] |
||||






